Mackay Shields LLC’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-9,600
| Closed | -$915K | – | 1601 |
|
|
2020
Q2 | $915K | Sell |
9,600
-18,990
| -66% | -$1.81M | 0.01% | 1054 |
|
|
2020
Q1 | $2.57M | Sell |
28,590
-18,100
| -39% | -$1.63M | 0.02% | 561 |
|
|
2019
Q4 | $2.48M | Sell |
46,690
-4,600
| -9% | -$244K | 0.02% | 784 |
|
|
2019
Q3 | $2.03M | Sell |
51,290
-1,600
| -3% | -$63.2K | 0.01% | 897 |
|
|
2019
Q2 | $2.17M | Buy |
52,890
+36,320
| +219% | +$1.49M | 0.01% | 868 |
|
|
2019
Q1 | $772K | Buy |
16,570
+100
| +0.6% | +$4.66K | 0.01% | 1070 |
|
|
2018
Q4 | $718K | Sell |
16,470
-1,713
| -9% | -$74.7K | 0.01% | 1038 |
|
|
2018
Q3 | $1.04M | Buy |
18,183
+700
| +4% | +$40.1K | 0.01% | 866 |
|
|
2018
Q2 | $848K | Buy |
17,483
+1,400
| +9% | +$67.9K | 0.01% | 1000 |
|
|
2018
Q1 | $629K | Buy |
+16,083
| New | +$629K | ﹤0.01% | 1080 |
|